We suggest that all patients negative for COL1A1/2 pathogenic variants be tested for the presence of an IFITM5 pathogenic variant, even if they are not expressing typical OI type V symptoms. The gene discussed is IFITM5; the disease is osteogenesis imperfecta type 5.